How effective is CDK4/6 inhibitor therapy for hormone receptor-positive breast cancer?

CDK4/6 inhibitors block proteins that help cancer cells move through the cell cycle. They are usually paired with endocrine treatment, which reduces or blocks hormone signalling. Doctors judge benefit through symptoms, examination, blood tests and scans. The aim may be to prevent recurrence after initial treatment or to control advanced disease, depending on the situation. Response is individual and treatment may need adjustment if side effects develop.

Take the medicine exactly as prescribed and keep the monitoring appointments arranged by your oncology team. Ask which blood tests are needed, what to do after a missed dose, and whether medicines, supplements or grapefruit products could interact with it. Report fever, infection symptoms, diarrhoea, marked tiredness or new breathlessness rather than stopping treatment without advice. Dose changes can sometimes preserve treatment while reducing side effects.

Get urgent medical advice for fever, chills, severe breathlessness, chest pain, fainting, uncontrolled diarrhoea, or signs of an allergic reaction. A CDK4/6 inhibitor can lower infection-fighting blood cells or, depending on the medicine, affect the liver, heart rhythm or lungs. Your team will tell you which symptoms require emergency care and which can be reviewed the same day.

Which CDK4/6 inhibitor fits my treatment plan? How will you measure benefit? Which side effects should prompt a same-day call? How will this medicine fit with endocrine treatment and other medicines I take?